Table 3.
Perioperative characteristics of patients with HCV with 2-year mortality compared with those without after undergoing primary elective TJA
| Variable | Mortality (n = 16) | No mortality (n = 153) | p value |
| TJA type | |||
| THA | 75 (12) | 47 (72) | 0.04 |
| TKA | 25 (4) | 53 (81) | |
| Operative duration in minutes | 91 ± 34 | 102 ± 35 | 0.15 |
| Blood loss in mL | 200 ± 12 | 200 ± 17 | 0.72 |
| Implant details | |||
| Cemented | 38 (6) | 55 (84) | 0.29 |
| Antibiotic cement (in cemented cases) | 33 (2) | 56 (47) | 0.41 |
| ASA score | 0.16 | ||
| 1 | 0 (0) | 1 (1) | |
| 2 | 13 (2) | 18 (28) | |
| 3 | 75 (12) | 78 (120) | |
| 4 | 12 (2) | 3 (4) | |
| Tranexamic acid use | 44 (7) | 33 (51) | 0.40 |
| General anesthesia | 88 (14) | 78 (119) | 0.53 |
| Intraoperative blood transfusion | 0 (0) | 1 (1) | > 0.99 |
| Intraoperative blood transfusion volume in units pRBCs | 0 (NA) | 2 (NA) | > 0.99 |
| Hemovac drain | 50 (8) | 73 (111) | 0.08 |
Data presented as % (n) or mean ± SD. ASA = American Society of Anesthesiologists; pRBCs = packed red blood cells.